A global ultrasound devices market report has added to the Research and Markets offering. According to the “Global Ultrasound Devices Market — Segmented by Application, Technology, Type, and Geography – Growth, Trends, and Forecast (2018-2023)” report, the market is expected to register a CAGR of about 4 percent during 2018-2023. The
Metactive Medical Inc., a Kansas medical device company developing products for the treatment of neurovascular and peripheral vascular diseases, announced today that Kieran Murphy, professor, vice chair and director of research in the department of Medical Imaging at the University of Toronto, presented new nonclinical results from Metactive’s peripheral vascular
Vici venous stent Boston Scientific has signed an agreement to acquire Veniti, a privately-held company in Fremont, California, which developed and commercialized the Vici venous stent system for treating venous obstructive disease. Boston Scientific has been an investor in Veniti since 2016 and owned 25 percent of the company. The transaction price for the
Medical groups have applauded steps that the Centers for Medicare & Medicaid Services took to ease administrative burden through a new rule on hospital payments, while still pressing the agency for further changes in its approach to electronic health records. On Aug. 2, the CMS unveiled the final version of
Microsoft is developing new blood pressure monitoring technology called Glabella, which comes equipped on a pair of glasses that passively collects physiological data on the wearer, according to a research paper recently released by the company. The paper was written by Christian Holz, Microsoft Research in Redmond; and Edward J.